Skip to content

Public FDA record

Z-1231-2010: Leksell Gamma Knife Perfexion. Radionuclide radiation therapy system. Elekta, Inc. Norcross, GA. Indic

Recall record Z-1231-2010 for Elekta, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1231-2010
Company in FDA record
Elekta, Inc.
FDA classification date
Apr 5, 2010
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

There has been an issue with "Image Fushing" where low precision calculation caused images to become inaccurate.

Source facts

Action
Elekta, Inc. issued a Field Change Order, Reference Number 0000946 dated March 14, 2008. Consignees were informed of the affected product and instructed on necessary steps to take. For further information, contact Elekta, Inc. at 1-770-300-9725.
Initiated
2007-05-30
Root cause
Software design
Terminated
2010-12-28
Distribution
Nationwide Distribution -- AR, AZ, CA, FLA, IL, MI, MN, MO, MS, NJ, OH, OR, PA, UT and VA.
Recall number
Z-1231-2010
Recall status
Terminated
CDRH record ID
89377
FDA classified
2010-04-05
Recall event number
54886

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗